Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
31.42
+0.77 (2.51%)
Sep 22, 2026, 3:16 PM EDT - Market open
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $8.88 billion as of September 22, 2026. Its market cap has decreased by -3.09% in one year.
Market Cap
8.88B
Enterprise Value
8.54B
1-Year Change
-3.09%
Ranking
Category
Stock Price
$31.42
ChartMarket Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has increased from $5.95B to $8.88B, an increase of 49.11%. That is a compound annual growth rate of 37.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 8.88B | 16.64% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cytokinetics | 9.56B |
| Arrowhead Pharmaceuticals | 9.39B |
| Protagonist Therapeutics | 9.25B |
| ABIVAX Société Anonyme | 9.10B |
| ImmunityBio | 8.99B |
| Vaxcyte | 8.65B |
| Praxis Precision Medicines | 8.35B |
| TG Therapeutics | 8.07B |